These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1668764)

  • 1. Plasma levels and mode of excretion of the anaphylatoxins C3a and C4a in renal disease.
    Abou-Ragheb HH; Williams AJ; Brown CB; Milford-Ward A
    J Clin Lab Immunol; 1991 Jul; 35(3):113-9. PubMed ID: 1668764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis.
    Abou-Ragheb HH; Williams AJ; Brown CB; Milford-Ward A
    Nephron; 1992; 62(1):22-6. PubMed ID: 1436286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus.
    Lappas M
    Diabet Med; 2011 Aug; 28(8):906-11. PubMed ID: 21615487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
    Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
    Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxins in preterm and term labor.
    Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
    J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
    Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma histamine but not anaphylatoxin levels correlate with generalized urticaria from infusions of anti-lymphocyte monoclonal antibodies.
    Dykewicz MS; Rosen ST; O'Connell MM; Patterson R; Kuzel TM; Gilyon KA
    J Lab Clin Med; 1992 Aug; 120(2):290-6. PubMed ID: 1500827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement split products c3a and c4a in chronic lyme disease.
    Stricker RB; Savely VR; Motanya NC; Giclas PC
    Scand J Immunol; 2009 Jan; 69(1):64-9. PubMed ID: 19140878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ; Sidikaro Y; Sumner H
    Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
    Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
    J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
    Mack WJ; Ducruet AF; Hickman ZL; Garrett MC; Albert EJ; Kellner CP; Mocco J; Connolly ES
    Neurosurgery; 2007 Aug; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glomerular filtration markers in pediatrics].
    Prévot A; Martini S; Guignard JP
    Rev Med Suisse Romande; 2002 Dec; 122(12):625-30. PubMed ID: 12611189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S; Sakurabayashi I
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract]   [Full Text] [Related]  

  • 18. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    Clin Exp Immunol; 1990 May; 80(2):167-70. PubMed ID: 2357842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
    Yamasaki M
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):234-41. PubMed ID: 2788676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
    Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
    Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.